Navigation Links
Porcine Vaccine Market, and Porcine Circovirus Associated Disease; End User - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Date:1/5/2017

NEW YORK, Jan. 4, 2017 /PRNewswire/ -- North America Porcine Vaccine Market: Scope of the Report

This report on the porcine vaccine market analyzes the current and future scenario of the North America market. Increase in disease indication among swine, technological advancement of RNA strand methodology, and cultivation of pig for growth in standard of living is accounted to form growth in porcine vaccine segment. Increase trading facilities of live hogs/pigs, demand of pork meat and innovation through clinical research activities are some of the drivers expected to drive the North America porcine vaccine market during the forecast period.

The North America porcine vaccine market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country's market with respect to the segments based on disease indication, technology, end-user, and country. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the North America porcine vaccine market.

North America Porcine Vaccine Market: Segmentation

Based on disease indication, the market has been segmented into diarrhoea, swine influenza, porcine reproductive and respiratory virus (PRRSV), porcine circovirus associated disease (PCVAD) and others. Diarrhoea is the most widely spread disease across the North America; porcine epidemic diarrhea virus (PEDV) hit the United States in 2013 and spread to Canada in 2014 which infected piglets and has 80%-100% mortality rate. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from veterans for treating the swine with various disease indications. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on technology, the North America porcine vaccine market has been segmented into inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. The market segments have been extensively analyzed based on increase in demand for disease treatment such as PEDv, PRRSv, and PCVAD. Demand of disease free pork meat, and increasing awareness for treating the cultivated pigs are driving the market share of technological segment. Different types of end-user utilize porcine vaccines to treat swine diseases either. Under the end-user segment, hog/pig production farms plays a major role followed by veterinary hospitals. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

North America Porcine Vaccine Market: Geographical and Competitive Dynamics

Geographically, the North America porcine vaccine market has been categorized into key countries: North America (the U.S. and Canada). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

The report also profiles major players in the North America porcine vaccine market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Bayer AG., Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck & Co., Inc., Merial (Sanofi), Vetoquinol, Zoetis Inc. and others.

The North America porcine vaccine market has been segmented as follows:

North America Porcine Vaccine Market, by Disease Indication

Diarrhoea
Swine Influenza
Arthritis
Bordatella Rhinitis
Porcine Reproductive and Respiratory Virus (PRRSV)
Porcine Circovirus Associated Disease (PCVAD)
Others

North America Porcine Vaccine Market, by Technology

Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines

North America Porcine Vaccine Market, by End-user

Veterinary Hospitals
Hog/Pig Production Farm

North America Porcine Vaccine Market, by Country

North America
U.S.
Canada

Read the full report: http://www.reportlinker.com/p04519452-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/porcine-vaccine-market-and-porcine-circovirus-associated-disease-end-user---north-america-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300385972.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. PRRS Vaccine Market 2018 Forecasts for China: Porcine Reproductive & Respiratory Syndrome is a Major Attraction for Animal Health Enterprises
2. North America Porcine Vaccine Market to US$926.2 Million by 2024: High Cost of Maintaining Cold Chains to Hinder Growth
3. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
4. Cancer Vaccine Partnering Terms and Agreements
5. A*STAR and Cytos Bring Singapores First Influenza Vaccine to Clinical Testing
6. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
7. iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza
8. Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
9. Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
10. Goodwin Biotechnology Announces Process Development Sub-Contract for an Anthrax Vaccine
11. Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... , June 14, 2017 The Bio ... City of Fremont and the ... the bio-pharma industry in California ... enabling executive networking, and fostering workforce development. The primary ... and growth of start-ups, as well as small and ...
(Date:6/12/2017)... 12, 2017 Kineta, Inc., a biotechnology company focused ... Vice President of R&D and Head of Virology Kristin ... Preparedness for the Northwest and Beyond meeting sponsored by ... 14, 2017 from 8:30-10:30 AM PDT at the Agora Conference ... Dr. Bedard will be joined by other leaders in ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... 25, 2017 , ... Republicans in the United States Senate on Thursday released ... Care Reconciliation Act. It differs significantly from the American Health Care Act, which the ... committee, or the House will have to take up the Senate version as-is, if ...
(Date:6/24/2017)... , ... June 24, 2017 , ... ... offering genetic testing for medications in select Florida and Texas doctors' offices and ... , This new application of genetic testing recognizes the role genes play in ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Military ... president's nominee for deputy secretary of Veterans Affairs, retired Marine Col. Thomas G. Bowman. ... Affairs. , Bowman brings an intimacy with the issues and challenges veterans ...
(Date:6/23/2017)... ... , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach ... proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does more ... can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach ...
Breaking Medicine News(10 mins):